Veracyte Inc’s recently made public that its Director JONES EVAN/ FA unloaded Company’s shares for reported $0.18 million on Sep 19 ’24. In the deal valued at $35.23 per share,5,173 shares were sold. As a result of this transaction, JONES EVAN/ FA now holds 0 shares worth roughly $0.0.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Leite John sold 5,479 shares, generating $163,159 in total proceeds. Upon selling the shares at $29.78, the Chief Commercial Officer-CLIA now owns 76,174 shares.
Before that, JOHN LEITE bought 5,479 shares. Veracyte Inc shares valued at $165,959 were divested by the Officer at a price of $30.29 per share.
UBS initiated its Veracyte Inc [VCYT] rating to a Buy in a research note published on October 16, 2024; the price target was $43. A number of analysts have revised their coverage, including Guggenheim’s analysts, who began to cover the stock in early October with a ‘”a Buy”‘ rating. Needham also remained covering VCYT and reiterated its “Buy” recommendation on February 23, 2024. Raymond James revised its rating on January 18, 2023. It rated VCYT as “a Mkt perform” which previously was an “an Outperform”.
Price Performance Review of VCYT
On Monday, Veracyte Inc [NASDAQ:VCYT] saw its stock jump 3.30% to $34.12. Over the last five days, the stock has gained 3.02%. Veracyte Inc shares have risen nearly 24.03% since the year began. Nevertheless, the stocks have risen 67.09% over the past one year. While a 52-week high of $35.51 was reached on 09/19/24, a 52-week low of $18.61 was recorded on 04/18/24. SMA at 50 days reached $32.62, while 200 days put it at $25.32.
Levels Of Support And Resistance For VCYT Stock
The 24-hour chart illustrates a support level at 33.38, which if violated will result in even more drops to 32.64. On the upside, there is a resistance level at 34.61. A further resistance level may holdings at 35.10. The Relative Strength Index (RSI) on the 14-day chart is 56.41, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.10, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 27.54%. Stochastics %K at 50.80% indicates the stock is a holding.
How much short interest is there in Veracyte Inc?
A steep rise in short interest was recorded in Veracyte Inc stocks on 2024-10-15, dropping by -0.4 million shares to a total of 3.1 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-13 was 3.5 million shares. There was a decline of -12.79%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on January 05, 2023 when Scotiabank began covering the stock and recommended ‘”a Sector outperform”‘ rating along with a $33 price target.
